This case demonstrates the value of endorectal MRI of the prostate in the initial staging and work-up of prostate cancer. In this patient with a palpable tumor and Gleason score 7 (4 + 3 ...

Background: A 59-year-old man on exogenous androgen therapypresented with a clinically palpable prostate nodule confined to onelobe on endorectal examination. Serum prostate-specific antigen was3 ...

TALAPRO-2 showed talazoparib and enzalutamide reduced death risk in mCRPC, effective across HRR gene alterations, highlighting the need for next-generation sequencing. STOPCAP meta-analysis found ...

If you want to reduce your risk of prostate cancer, research suggests that you may want to make more frequent date nights in bed, or simply engage in more self-pleasure. A study from the Harvard T.H.

Melbourne-based scientists have, for the first time, discovered how to "switch off" a molecule which is one of the top culprits behind prostate cancer, and is also linked to lung and kidney cancers.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer to improve screening, diagnosis and personalised treatment. The test identifies cancerous cells, signs of early and ...

About half of men with medium-risk prostate cancer have just one tumour, occupying only 5 to 10 per cent of the prostate, yet far too many are being steered towards radical treatment Paul Sayer ...

Sitting in the brain between its hypothalamus region and the pineal gland within the sphenoid bone (located towards the front of the skull), this gland has two lobes: an anterior and a posterior lobe.

There is no national screening programme for prostate cancer in the UK. This is because there isn’t a reliable test that can pick up prostate cancer that needs treatment at an early stage. Researchers ...